Orris
attachment
attachment

Answer it

Answer: D. Combination of b and c (fAUC/MIC and fCmax/MIC)
Aminoglycosides are concentration-dependent antibiotics. Their killing efficacy is best predicted by two PK/PD parameters working together:
  • fCmax/MIC - the peak concentration relative to the MIC drives rapid, concentration-dependent bacterial killing. A Cmax/MIC ratio of 8-10 is the classic target for aminoglycosides against gram-negative organisms.
  • fAUC/MIC - the total drug exposure over 24 hours relative to the MIC correlates with overall efficacy and is important for predicting outcomes, especially with once-daily dosing regimens.
This is why once-daily (extended-interval) dosing of aminoglycosides is preferred - it maximizes the Cmax/MIC peak while also allowing a drug-free interval (which reduces nephrotoxicity and exploits the post-antibiotic effect).
fTime/MIC (Option A) is the key parameter for time-dependent antibiotics like beta-lactams and vancomycin - NOT aminoglycosides.
So the correct answer is D.
attachment
attachment

Answer this

Answer: D. All the above
MIC (Minimum Inhibitory Concentration) is a static, single time-point measurement performed under artificial lab conditions. It has several well-recognized limitations as a sole measure of antimicrobial activity:
  • A. Does not consider time course of antimicrobial activity - MIC only tells you the concentration needed to inhibit growth at one point in time. It says nothing about how fast killing occurs, or whether the drug needs to stay above the MIC continuously (time-dependent) or just reach a high peak (concentration-dependent).
  • B. Does not mimic physiologic conditions - MIC testing is done in standardized broth at fixed pH, temperature, protein binding, and inoculum. In vivo, drug concentrations fluctuate, protein binding varies, and the immune system contributes to bacterial killing - none of which are captured by the MIC.
  • C. Does not consider the sub-MIC effect and post-antibiotic effect (PAE) - Sub-MIC concentrations can still suppress bacterial growth and alter organism morphology. The PAE refers to continued suppression of bacterial growth after drug concentrations fall below the MIC. MIC testing ignores both of these phenomena entirely.
This is precisely why PK/PD parameters (fAUC/MIC, fCmax/MIC, fTime>MIC) were developed - to overcome the limitations of MIC as a standalone metric.
Correct answer: D
attachment
attachment

Answer

Answer: C. Gram-positive coccal organisms
Gram-positive cocci are by far the most frequent cause of central venous access device (CVAD)-related bloodstream infections (CR-BSIs). The top pathogens are:
  • Coagulase-negative staphylococci (CoNS) - e.g., S. epidermidis - the single most common cause overall. They colonize catheter surfaces and form biofilms.
  • Staphylococcus aureus (including MRSA) - second most common, and associated with the most serious outcomes.
  • Enterococci (E. faecalis, E. faecium) - also gram-positive cocci, particularly in immunocompromised patients.
Why the other options are wrong:
  • A. Candida spp. - Candida is an important cause of CR-BSI (especially in ICU, TPN patients, immunocompromised), but it ranks behind gram-positive cocci in overall frequency.
  • B. Mixed aerobic and anaerobic bacteria - this pattern is more typical of intra-abdominal or polymicrobial infections, not catheter-related BSI.
  • D. Enterobacteriaceae - gram-negative rods are less common than gram-positive cocci in CR-BSI, though they do occur (more common in oncology/neutropenic patients).
The skin flora (primarily gram-positive cocci) is the dominant source of catheter contamination, either at insertion or via hub colonization - which is why aseptic technique and chlorhexidine skin prep are the cornerstone of prevention.
Correct answer: C
attachment
attachment

Answer this

Answer: A. An initial loading dose of approximately 25-30 mg/kg should be administered.
Here is the reasoning for each option:
Why A is correct:
In septic patients, vancomycin pharmacokinetics are altered - increased volume of distribution (Vd) means drug gets diluted into a larger compartment. To rapidly achieve therapeutic AUC/MIC targets (the current gold-standard PK/PD goal for vancomycin), current ASHP/IDSA/SIDP 2020 guidelines recommend:
  • Loading dose of 25-30 mg/kg (based on actual body weight) for serious/severe infections
  • This rapidly achieves therapeutic concentrations without waiting for steady state
  • Particularly important in sepsis where delays in achieving therapeutic levels worsen outcomes
Why the others are wrong:
  • B. Subsequent dosing = one-third of loading dose every 12 hours - This is incorrect. Maintenance dosing is typically 15-20 mg/kg every 8-12 hours in normal renal function, guided by AUC monitoring (target AUC/MIC of 400-600 mg·h/L). "One-third every 12 hours" is not a recognized dosing strategy.
  • C. Adjust subsequent dosing based on CRP - CRP is an inflammatory marker, not a PK parameter. Vancomycin dosing is adjusted based on AUC monitoring (or trough levels where AUC monitoring is unavailable), renal function, and clinical response - never CRP.
  • D. Start very low and titrate up - This approach would cause dangerous delays in achieving therapeutic concentrations in a septic patient, worsening mortality. Sepsis demands rapid attainment of therapeutic drug levels.
Correct answer: A
attachment
attachment

Answer

Answer: C. Pseudomonas
The SPICE organisms (also called SPICE-M or ESCAPPM) are a group of gram-negative bacteria that harbor inducible AmpC beta-lactamases and are prone to developing resistance during therapy:
LetterOrganism
SSerratia spp.
PProvidencia spp.
IIndole-positive Proteus (P. vulgaris, P. penneri)
CCitrobacter freundii
EEnterobacter spp.
Pseudomonas aeruginosa is NOT part of the SPICE group. While Pseudomonas is certainly a clinically important resistant organism, it is not classified under SPICE. Its resistance mechanisms are different (efflux pumps, porin loss, metallo-beta-lactamases) rather than inducible AmpC.
Why SPICE matters clinically:
  • These organisms can appear susceptible to 3rd-generation cephalosporins (e.g., ceftriaxone) on initial testing
  • During treatment, AmpC can be de-repressed/induced, causing the organism to become resistant mid-therapy
  • This is why carbapenems or cefepime (which are stable to AmpC) are preferred for serious SPICE infections, even if initial sensitivities show susceptibility to 3rd-gen cephalosporins
Correct answer: C - Pseudomonas
This is a shared conversation. Sign in to Orris to start your own chat.